Jeremy Grantham's CVS Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 760,952 shares of CVS Health Corporation (CVS) worth $57.37 M, representing 0.16% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 1.01 M shares. Largest reduction occurred in Q1 2014, reducing 1.7 M shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +2.31 M | Add 0.00% | 2.31 M | $57.18 |
| Q3 2013 | +595,854 | Add 25.83% | 2.9 M | $56.75 |
| Q4 2013 | +442,526 | Add 15.24% | 3.35 M | $71.57 |
| Q1 2014 | -1.7 M | Reduce 50.71% | 1.65 M | $74.86 |
| Q2 2014 | -1.54 M | Reduce 93.38% | 109,100 | $75.37 |
| Q3 2014 | +238,700 | Add 218.79% | 347,800 | $79.59 |
| Q4 2014 | -121,500 | Reduce 34.93% | 226,300 | $96.31 |
| Q1 2015 | +822,725 | Add 363.56% | 1.05 M | $103.21 |
| Q2 2015 | +1.01 M | Add 96.25% | 2.06 M | $104.88 |
| Q3 2015 | +339,172 | Add 16.47% | 2.4 M | $96.48 |
| Q4 2015 | -96,900 | Reduce 4.04% | 2.3 M | $97.77 |
| Q1 2016 | +18,099 | Add 0.79% | 2.32 M | $103.73 |
| Q2 2016 | -493,133 | Reduce 21.26% | 1.83 M | $95.74 |
| Q3 2016 | -681,481 | Reduce 37.32% | 1.14 M | $88.99 |
| Q4 2016 | -3,764 | Reduce 0.33% | 1.14 M | $78.91 |
| Q1 2017 | -37,428 | Reduce 3.28% | 1.1 M | $78.50 |
| Q2 2017 | +29,310 | Add 2.66% | 1.13 M | $80.46 |
| Q3 2017 | -67,589 | Reduce 5.97% | 1.07 M | $81.32 |
| Q4 2017 | -6,700 | Reduce 0.63% | 1.06 M | $72.50 |
| Q1 2018 | -1.06 M | Sold Out | 1.06 M | $0.00 |
| Q4 2020 | +239,500 | New Buy | 239,500 | $68.30 |
| Q1 2021 | +75,632 | Add 31.58% | 315,132 | $75.23 |
| Q2 2021 | +50,768 | Add 16.11% | 365,900 | $83.44 |
| Q3 2021 | +17,900 | Add 4.89% | 383,800 | $84.86 |
| Q4 2021 | -81,200 | Reduce 21.16% | 302,600 | $103.16 |
| Q1 2022 | -61,800 | Reduce 20.42% | 240,800 | $101.21 |
| Q2 2022 | +83,900 | Add 34.84% | 324,700 | $92.66 |
| Q3 2022 | +47,000 | Add 14.47% | 371,700 | $95.37 |
| Q4 2022 | +158,588 | Add 42.67% | 530,288 | $93.19 |
| Q1 2023 | +199,400 | Add 37.60% | 729,688 | $74.31 |
| Q2 2023 | +71,404 | Add 9.79% | 801,092 | $69.13 |
| Q3 2023 | +36,827 | Add 4.60% | 837,919 | $69.82 |
| Q4 2023 | -55,527 | Reduce 6.63% | 782,392 | $78.96 |
| Q1 2024 | -65,702 | Reduce 8.40% | 716,690 | $79.76 |
| Q2 2024 | +173,083 | Add 24.15% | 889,773 | $59.06 |
| Q3 2024 | +4,547 | Add 0.51% | 894,320 | $62.88 |
| Q4 2024 | -118,525 | Reduce 13.25% | 775,795 | $44.89 |
| Q1 2025 | +165,572 | Add 21.34% | 941,367 | $67.75 |
| Q2 2025 | -89,142 | Reduce 9.47% | 852,225 | $68.98 |
| Q3 2025 | -91,273 | Reduce 10.71% | 760,952 | $75.39 |
Jeremy Grantham's CVS Health Corporation Investment FAQs
Jeremy Grantham first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 2,306,974 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held CVS Health Corporation (CVS) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to CVS Health Corporation (CVS) was in Q2 2013, adding 2,306,974 shares worth $131.91 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 760,952 shares of CVS Health Corporation (CVS), valued at approximately $57.37 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 0.16% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in CVS Health Corporation (CVS) was 3,345,354 shares, as reported at the end of Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.